Skip to main content

Table 1 Patient characteristics

From: Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation

Parameters

N (male/female)

100 (61/39)

Age (years)

69.3 ± 9.6

Type of AF

 Paroxysmal [n (%)]

68 (68%)

 Persistent [n (%)]

20 (20%)

 Long-lasting [n (%)]

12 (12%)

 Duration of AF (months)

11.7 ± 17.9

 Hypertension [n (%)]

49 (49%)

 Diabetes [n (%)]

14 (14%)

 Structural heart disease [n (%)]

11 (11%)

 CHADS2

1.2 ± 1.0

 CHA2DS2-VASc

2.3 ± 1.3

 LVEF (%)

64.3 ± 7.8

 LAD (mm)

36.4 ± 7.3

 Ccr (mL/min)

62.0 ± 17.8

 BNP (pg/mL)

129.5 ± 191.4

  1. AF atrial fibrillation, LVEF left ventricular ejection fraction, LAD left atrium diameter, BNP brain natriuretic peptide